financetom
Business
financetom
/
Business
/
WeightWatchers Integrates With Eli Lilly To Expand Access To Zepbound, Stock Skyrockets 110%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
WeightWatchers Integrates With Eli Lilly To Expand Access To Zepbound, Stock Skyrockets 110%
May 25, 2025 8:58 PM

WW International Inc ( WW ) shares are trading higher by 110% to 87 cents during Tuesday’s session after the company announced a new partnership with Eli Lilly's LillyDirect pharmacy provider, Gifthealth, to simplify access to the popular weight loss drug Zepbound for its clinic members.

What To Know: WeightWatchers says this integration allows eligible self-pay patients, without insurance coverage, to receive prescriptions for Zepbound in single-dose vial form directly through the WeightWatchers app, which now includes real-time tracking and a streamlined fulfillment process.

Per WeightWatchers, Zepbound usage has surged among WeightWatchers Clinic members, with prescriptions for the vial format more than doubling in recent months.

WeightWatchers says, currently, 33% of the clinic's patients use Zepbound as part of their weight management plan. Executives from both WeightWatchers and Gifthealth emphasized the benefits of this integration in improving transparency, pricing and ease of access.

WeightWatchers also says the company continues to combine medical treatments like GLP-1s with behavioral support. Their approach has yielded significant results—patients have achieved an average 21% weight loss over 12 months, outperforming GLP-1 use alone.

Read Also: Coca-Cola Boasts Q1 EPS Beat As Revenue Jumps In Europe, Middle East And Africa

How To Buy WW Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in WW International’s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, WW has a 52-week high of $2.35 and a 52-week low of $0.12.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pan American Silver Q2 revenue beats expectations
Pan American Silver Q2 revenue beats expectations
Aug 6, 2025
Overview * Pan American Q2 revenue of $811.9 mln beats analyst expectations, per LSEG data * Adjusted EPS of $0.43 surpasses consensus estimates, per LSEG data * Record net earnings of $189.6 mln driven by high mine operating earnings Outlook * Pan American reaffirms 2025 guidance for silver production of 20-21 mln ounces * Pan American maintains 2025 AISC guidance...
Canada's Savaria beats Q2 adjusted EPS estimates
Canada's Savaria beats Q2 adjusted EPS estimates
Aug 6, 2025
Overview * Savaria ( SISXF ) Q2 revenue up 2.4% yr/yr, missed analyst expectations, per LSEG data * Adjusted EPS for Q2 beats consensus, reflecting improved operational performance * Adjusted EBITDA for Q2 exceeds estimates, indicating strong financial health Outlook * Savaria ( SISXF ) forecasts 2025 revenue of about C$925 mln, adjusted EBITDA margin at 20% * Company expects...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
ADMA Biologics Q2 revenue rises on increased ASCENIV utilization
ADMA Biologics Q2 revenue rises on increased ASCENIV utilization
Aug 6, 2025
Overview * ADMA Q2 revenue rises 14% yr/yr but just missed analyst expectations * Adjusted net income for Q2 beats estimates, reflecting strong operational performance * Co initiated FDA-approved yield enhancement process, boosting IG output by 20%+ Outlook * ADMA reaffirms FY 2025 revenue guidance over $500 mln * Company expects FY 2026 revenue to exceed $625 mln * Expects...
Copyright 2023-2026 - www.financetom.com All Rights Reserved